ask="6.80"
ask_size="200"
average_daily_volume="206665"
bid="5.15"
bid_size="100"
book_value="3.27"
change="-0.10"
change_from_200_day_moving_average="-4.94"
change_from_50_day_moving_average="-0.75"
change_from_52_week_high="-12.25"
change_From_52_week_low="0.20"
change_in_percent="-1.80%"
close="5.45"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.53"
ebitda="-19.35M"
eps_estimate_current_year="-2.81"
eps_estimate_next_quarter="-0.93"
eps_estimate_next_year="-2.55"
ex_dividend_date="N/A"
float_shares="5820000"
high="5.55"
high_52_weeks="17.70"
last_trade_date="1/18/2017"
last_trade_price="5.45"
last_trade_size="110"
last_trade_time="3:59pm"
low="5.30"
low_52_weeks="5.25"
market_capitalization="42.60M"
moving_average_200_day="10.39"
moving_average_50_day="6.20"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.86"
open="5.55"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-47.56%"
percent_change_from_50_day_moving_average="-12.14%"
percent_change_from_52_week_high="-69.21%"
percent_change_from_52_week_low="+3.81%"
previous_close="5.55"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.70"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="1.46"
stock_exchange="NCM"
symbol="TRIL"
volume="73462"
weeks_range_52="5.25 - 17.70"
